drugset

drugset / Trial / NCT03129295

Phase II Proof of Concept Study in Uncomplicated UTI

NCT03129295 ↗

Phase 2 Unknown 200 enrolled Mission Pharmacal

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

A study of the efficacy and safety of MPC-SHRC for the relief of symptoms associated with uncomplicated urinary tract infections.

Timeline

Start: 2017-04
Primary completion: 2017-09
Completion: 2017-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	MPC-SHRC	Unknown	—	Oral

Indications